First Trust Advisors LP Alector, Inc. Transaction History

First Trust Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.65 - $14.24 $897,964 - $1.67 Million	-117,381 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $336,384 - $536,872	-25,836 Reduced 18.04%	117,381 $1.67 Million
Q4 2021 Feb 08, 2022	BUY	$19.35 - $25.54 $2.77 Million - $3.66 Million	143,217 New	143,217 $2.96 Million
Q3 2021 Nov 15, 2021	SELL	$21.65 - $39.49 $1.26 Million - $2.3 Million	-58,304 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $903,712 - $1.31 Million	58,304 New	58,304 $1.21 Million
Q4 2020 Feb 02, 2021	SELL	$9.4 - $16.7 $174,473 - $309,968	-18,561 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$10.54 - $24.96 $1.33 Million - $3.15 Million	-126,284 Reduced 87.19%	18,561 $196,000
Q2 2020 Jul 22, 2020	BUY	$21.87 - $33.11 $1.21 Million - $1.83 Million	55,190 Added 61.56%	144,845 $3.54 Million
Q1 2020 May 06, 2020	BUY	$16.25 - $35.28 $1.46 Million - $3.16 Million	89,655 New	89,655 $2.16 Million

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $325M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.